Clinicians can adopt a combination of markers to stratify assessment among patients with non-ST elevation coronary syndromes which, in turn, will identify those among whom the risk of cardiac death or non-fatal myocardial infarction approaches 50 percent.
Researchers from the Department of Cardiology, St Bartholomew’s Hospital, London, England, in a prospective cohort study, determined the incremental value of clinical data, troponin T, ST segment monitoring, and heart rate variability, for predicting the outcomes.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!